BCCCP MBCIS Data Webinar. December 7, 2010
|
|
- Verity Day
- 5 years ago
- Views:
Transcription
1 BCCCP MBCIS Data Webinar December 7,
2 Featuring Ann Garvin, MS, CNM EJ Siegl, MA, OCN, RN Susan Harris, Ph. D. Cathy Blaze 2
3 Objectives 1. Describe how to document the different types of screening and diagnostic services delivered to program women based on the exam result and work-up plan. 2. Identify 1 example for each of the three exam types (screening, follow-up, surveillance) that are used in documenting program services in MBCIS. 3. Describe at least two unusual circumstances that require specific documentation and/or notification of nurse consultants for providing program services that deviate from the medical protocol. 3
4 Types of Office Visits Annual Screening Office Visit Follow-up Office Visit Breast or Cervical Consult Visit 4
5 Annual Screening Office Visit Purpose: Provide screening services (Clinical Breast Exam (CBE), Pap test (if indicated), Pelvic Exam) to identify a potential breast or cervical problem Scheduled > 365 days from date of last screening Does NOT have to be the same time every year Dates can be extended by a few months if results are normal from previous screening and caseload constraints prevent the woman from enrolling 5
6 Annual Screening Office Visit cont. Office Visits (annual and follow-up) are ALWAYS tied to a service: CBE, Follow-up CBE, Pap test, Follow-up Pap Test, Pelvic Exam Annual screenings are documented as OFFICE Visits (Full or Partial) depending on exams/tests performed. 6
7 Follow-up Office Visits Purpose: Examine the client with an identified breast or cervical abnormality post procedure or post imaging exam Type of visit documented depends on procedures performed Usually coded as partial office visit (follow-up is problem related) Scheduled when needed (some limitations apply as to # of visits, and type of monitoring required) 7
8 Breast or Cervical Consults Purpose: Examine the client with a NEW breast or cervical abnormality based on screening test results to determine appropriate diagnostic testing OR Examine a client post procedure for possible complications 8
9 Documenting Office Visits in MBCIS Annual/Follow-up Office Visits: Partial Office Visit (OV) CBE OR Pap and/or Pelvic (one body part examined) Full OV CBE AND Pap and/or Pelvic (both breast and cervical (2) body parts examined) Follow-up Office Visit entered as either a partial or full office visit following the rules above 9
10 Documenting Consults in MBCIS Breast/Cervical Consults: Billing: Consults CANNOT be billed!! Clinical: If client referred for consult; document the appropriate consult (BREAST or CERVICAL) in MBCIS Consultations are for data entry only, these codes are no longer approved BCCCP codes 10
11 Data Documentation in MBCIS Basic Data Entry Issues Opening/closing cycles based on visit type Enrollment dates Referral dates 11
12 Basic Data Entry Issues No extra spaces, hyphens, or other special characters in any of the data entry text boxes (i.e. Names, Comments, etc.) 12
13 Opening/Closing Cycles Based on Visit Type Open initial cycle for new clients (never screened in program previously) Open anniversary cycle for clients returning for annual screening Open anniversary cycle for clients returning for follow up of new abnormality prior to annual screening 13
14 Enrollment Dates Date the client was enrolled or re-enrolled in the program (i.e. date eligibility information obtained or date woman completed enrollment paperwork) It does not need to match the first date of service This date can be the same as or before the client s first screening service date The enrollment date cannot be after the first date of service 14
15 Referral Dates Date a client was referred by a non-bcccp provider to the program; OR Date that client was first seen by the program To ensure timeliness of care, date of non BCCCP service should not be used as the referral date Document the referral date on the service summary screen 15
16 Exam Types Screening Follow-up/Diagnostic Surveillance 16
17 Screening Exams Performed ONCE yearly NEW CYCLE always opened for screening exams Are NOT a follow-up exam that is monitoring a previously identified abnormality Includes the following EXAM types: CBE, Mammogram-Screening (OR Diagnostic-depending on history) Pap test, Pelvic Exam Office Visit Type: Full (CBE and Pap/Pelvic) or Partial (CBE OR Pap/Pelvic) CAD is not a payable procedure 17
18 Follow-up Clinical Exams Clinical Exam Types: Follow-up Pap Tests performed > 6 months post screening Pap test or post cervical biopsy Follow-up CBE - performed > 2 months from screening CBE Follow-up exams are linked with PARTIAL Office Visits (unless both breast and cervical body parts are examined) 18
19 Follow-up Diagnostic Exams cont. Diagnostic Mammograms A True Diagnostic Mammogram is performed: Post screening mammogram result of ACR 0 - Additional Work-up Required 6 months post ACR 3 - Probably Benign Immediately Post breast biopsy to evaluate clip or wire placement > 2 months post breast biopsy to evaluate status of abnormality 19
20 Other Diagnostic Exams Include the following BCCCP reimbursed services Ultrasound Colposcopy ANY type of Breast or Cervical Biopsy Post biopsy mammogram/clip placement Non-BCCCP Reimbursed services MRI s, Ductograms, etc. Any diagnostic service that determines a final diagnosis 20
21 Surveillance Exams Two types: Mammogram Surveillance and Pap Surveillance Used to distinguish abnormal result requiring follow-up Enter as FIRST exam in a new cycle Surveillance exams are NEVER entered as followup exams in current cycle 21
22 Additional Information Appropriate funding (Federal, State, Non-BCCCP, Other) based on referral source and exam type Most exams should be coded as Funding Federal Screening Mammograms for yr olds should be coded as Funding State Services provided outside of the program should be coded as Funding Non-BCCCP Repeat exams (Mammograms, Pap Tests) Repeat exams are screening exams that have an initial unsatisfactory result the image or labs could not be read properly. The initial exam is coded as unsatisfactory, the second screening exam should be coded as repeat. 22
23 Documenting Follow-up Services Follow-up CBE, Follow-up Pap test, Diagnostic Mammogram Diagnostic LEEP, Diagnostic Cone, Endometrial Biopsy (EMB) 23
24 Documenting Follow-up Exams Documentation Guidelines Normal/benign results requiring no follow-up or short-term follow-up Document in the SAME cycle as screening exams Abnormal results requiring immediate follow-up Open a NEW cycle in MBCIS Code abnormality as Mamm / Pap Surveillance 24
25 Follow-up Pap Test (same for F/U CBE) 25
26 Documenting Follow-up Services: Breast Breast Biopsy (inclusive category) covers ALL BCCCP reimbursed biopsies Ultrasound (US) Diagnostic Mammogram New Exam type: Post Biopsy Mammogram/Clip Placement Appropriate use of Other Diagnostic Procedure Breast: DO NOT USE For questions re: data entry call State Nurse Consultant (NC) 26
27 Follow-up/Diagnostic Mammogram 27
28 Documenting Follow-up Services: Cervical Biopsy types: ECC (endocervical curettage), cervical biopsy Appropriate use of Other Diagnostic Procedure - Cervical?: DO NOT USE Use of subsequent follow-up services: follow-up Pap and/or follow-up colp x1 For questions re: data entry call NC 28
29 Documenting Follow-up Services: Cervical EMB: for AGC Pap result only Not for endometrial cells present in woman >age 40 or any other result Contact NC with MBCIS# and date of EMB NC will enter into MBCIS 29
30 Documenting Follow-up Services: Cervical Diagnostic LEEP and Diagnostic Cone For Pap results of HSIL or AGC only For colp results of CIN1/ not cancer /atypia/unsatisfactory only CIN2+ receives Medicaid for treatment LEEP/Cone are now TREATMENT NC enters into MBCIS: contact w/ MBCIS#, date and type of dx procedure Final dx date: date of dx LEEP or cone 30
31 Documenting Surveillance in MBCIS Mammogram Surveillance Used in the following 4 situations: When a client has an abnormal CBE and is referred for a mammogram When a client is referred from a non-bcccp provider to the program for diagnostic work-up for an abnormal Mammogram To open a new cycle mid-year because the follow-up Diagnostic mammogram is abnormal and requires additional diagnostic tests After radiologist issues final ACR result from a film comparison. 31
32 Use of Mammogram Surveillance Abn STF additional F/U required 32
33 33
34 Use of Mammogram Surveillance: Film Comparison Screening Mammogram result on 12/15/08; Radiologist wants previous films for comparison. What is the result of the Screening Mammogram in this instance? Work-up Plan = Short-term Comparison Film obtained Radiologist amends final result on 1/28/09 to ACR 2 Benign Finding 34
35 Use of Mammogram Surveillance: Film Comparison 35
36 Pap Surveillance Used in the following 3 situations: When a client is referred from a non-bcccp provider (E.g. Family Planning Clients) to the program for diagnostic work-up for an abnormal Pap test To open a new cycle mid-year because the follow-up Pap test is abnormal and requires additional diagnostic tests To document yearly Pap tests for women with a history of CIN 2-3 (20 years) or hysterectomy for dysplasia or cervical cancer ( forever ) 36
37 Use of Pap Surveillance 37
38 NEW Exam Types Post biopsy mammogram/clip placement No Result is Required. DO NOT USE OTHER for this exam Non-Standard Care Used by Nurse Consultants ONLY to document clinical care that deviates from medical protocol 38
39 Appropriate Coding of Final Diagnosis Data/Date Work-up Complete: finished w/ final dx Refused: if patient refuses to have care Put in date and Not Applicable for dx Lost to Follow-up: can t find patient Put in date and Not Applicable for dx Not Applicable Work-up Interrupted: dx in process (left country, other health issues) Put in date and Not Applicable for dx Treatment Start Date Diagnostic LEEP or Cone: treatment started, date of LEEP/Cone, type surgery Surgery, Chemo, etc date of surgery, start of chemo, etc Data Deletion any deletion on the service summary screen will delete the diagnosis and treatment data. You will need to re-enter the diagnosis and treatment data! 39
40 Special Circumstances Multiple Surgical Consults Multiple tests/procedures pre and post biopsy Complications post biopsy Nurse Consultant Approval Exams/ procedures Non-Standard Care Documenting No Treatment for CIN 2 Clients < age 30 40
41 Multiple Surgical Consults Multiple Surgical Consults Breast consults - Reimburse up to 2 surgical consults/office visits per year: Pre breast biopsy, and immediately post breast biopsy. Cervical Consults - Reimburse for consult on DAY of cervical diagnostic procedure. If cancer diagnosed, will reimburse for post biopsy consult/office visit Additional breast and cervical consults beyond guideline above require NC approval; reviewed on case by case basis 41
42 Multiple Tests Procedures Imaging Tests Pre and post biopsy US and US guided biopsy reimbursed ONLY in select circumstances Complications post breast biopsy surgical consults (# dependant on problem) reimbursed to evaluate biopsy induced infection/hematoma 42
43 Nurse Consultant Approval Exams/procedures NC Approval required for: Diagnostic LEEP, Diagnostic Cone, EMB ANY consult/exam/procedure reimbursed by BCCCP that deviates from medical protocol Non-Standard Care -- ANY consult/exam/procedure NOT reimbursed by BCCCP that deviates from medical protocol BUT impacts FINAL diagnosis 43
44 Documenting No Treatment for CIN 2 Clients < age 30 If plan is follow with colp/pap at 6 months Put in treatment, not needed and put in comments Pap/colp in 6 months After 1 st follow-up Pap/colp, if still NO treatment planned, patient returns to care of Family Planning for surveillance (no data in MBCIS) If situation changes (now CIN3/CIS and/or treatment), BCCCP will provide care 44
45 Questions! Ann Garvin MS, CNM Susan Harris, PH. D E.J. Siegl MA, OCN, RN Cathy Blaze
BCCCNP NEW PROGRAM FORMS WEBINAR. January 8, 2019 E.J. Siegl, Program Director Breast and Cervical Cancer Control Navigation Program
BCCCNP NEW PROGRAM FORMS WEBINAR January 8, 2019 E.J. Siegl, Program Director Breast and Cervical Cancer Control Navigation Program NEW GRANT CHANGE IN FOCUS New Clinical Data Requirements by CDC for BCCCNP
More informationBREAST AND CERVICAL CANCER CONTROL NAVIGATION PROGRAM MEDICAL PROTOCOL OCTOBER 2018
1 TABLE OF CONTENTS I. Introduction page 2 II. BCCCNP Clinical Services Provided to Eligible Clients - page 3 III. BCCCNP Age and Insurance Eligibility to Receive Breast and Cervical Cancer Screening and/or
More informationMichigan Breast and Cervical Cancer Control Program Billing Manual Fiscal Year 2010
Michigan Breast and Cervical Cancer Control Program Billing Manual Fiscal Year 2010 Table of Contents 12/14/2009 Intentionally left blank Table of Contents History and Overview 1 Residency Requirement..1
More informationCase Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure
Disclosure Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Associate Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics This
More informationFY 2017 BCCCNP Unit Cost Reimbursement Rate Schedule
1 Screening Mammogram (Bilateral) 1a. ** NEW **- 01/01/2017- ** Replaces 77057** Screening Mammogram (Bilateral) 2 Digital Screening Mammogram (Bilateral) Service CPT Code 2a. Screening Breast Tomosynthesis
More informationBCCCNP Service CPT Code FY 2019 Rate Oct 1, 2018 Dec 31, 2018
1 Screening Mammogram (Bilateral); including CAD Service CPT Code 77067 77067-TC 77067-26 $111.40 $81.32 $30.08 $131.51 $93.70 $37.82 * Note: Breast tomosynthesis, unilateral (77061) and bilateral (77062)
More informationSW MI Breast & Cervical Cancer Control Navigation Program (FONDLY KNOWN AS BCCCNP)
SW MI Breast & Cervical Cancer Control Navigation Program (FONDLY KNOWN AS BCCCNP) Program Eligibility Age 40 64 for breast/cervical screening/diagnostic/treatment services Age 21 39 for breast/cervical
More informationWhat is a Pap Smear and What do the results mean? Maria E Daheri RN Cervical Nurse Case Harris Health System
What is a Pap Smear and What do the results mean? Maria E Daheri RN Cervical Nurse Case Manager @ Harris Health System What is a Pap Smear and when is it recommended? Pap smear The Pap smear is a screening
More informationBCCCNP Service CPT Code FY 2019 Rate Oct 1, 2018 Dec 31, 2018
1 Screening Mammogram (Bilateral); including CAD 2 Screening Breast Tomosynthesis (Bilateral) 3D Mammogram ** Can only be paid w/ screening mammography (77067))** 3 Diagnostic Mammogram (Unilateral); including
More informationClinical Breast Examination N/A Yes Screening Mammogram $ TC $ 43.56
For the Period 07/01/2015 through 06/30/2016 Revised: 10/09/2015 Breast Procedures (1) Screening Clinical Breast Examination N/A Screening Mammogram 77057 $ 78.38 77057-TC $ 43.56 77057-26 $ 34.82 Follow-Up
More informationManagement Algorithms for Abnormal Cervical Cytology and Colposcopy
Management Algorithms for Abnormal Cervical Cytology and Colposcopy Table of Contents Standard Colposcopic Definitions... 1 Guidelines for the Assessment of Abnormal Cervical Cytology... 2 Ia: Persistent
More informationState Breast and Cervical Cancer Early Detection Program WEAVING Survey
State Breast and Cervical Cancer Early Detection Program WEAVING Survey When complete, please email this survey to info@uihi.org OR fax to 206-812-3044 1. Organization Name: 2. State: 3. From the list
More informationFoundational funding sources allow BCCHP to screen and diagnose women outside of the CDC guidelines under specific circumstances in Washington State.
Program Description The Breast, Cervical and Colon Health Program (BCCHP) screens qualifying clients for breast cancer. The program is funded through a grant from the Centers for Disease Control and Prevention
More informationAlabama Department of Public Health County Health Department Protocol
Alabama Department of Public Health County Health Department Protocol BREAST AND CERVICAL CANCER TABLE OF CONTENTS ABCCEDP Overview and Purpose... 1 Clinical Guidelines... 1 Patient Enrollment... 1 Resource
More informationBCCCNP Service CPT Code FY19 Rate. $ $97.98 $ Diagnostic Breast Tomosynthesis (Bilateral) 3D Mammogram a. Global
1 Screening Mammogram (Bilateral) 2 Screening Breast Tomosynthesis (Bilateral) 3D Mammogram ** Can only be paid w/ screening mammography (77067))** 3 Diagnostic Mammogram (Unilateral) 4 Diagnostic Mammogram
More information$ $97.98 $ a. Diagnostic Breast Tomosynthesis (Bilateral) 3D Mammogram a. Global. $47.61 b. Technical/Facility Only
1 Screening Mammogram (Bilateral) 2 Digital Screening Mammogram (Bilateral) 2a. Screening Breast Tomosynthesis (Bilateral) 3D Mammogram ** Can only be paid w/ screening mammography (77067))** 3 Diagnostic
More informationEarly Detection Works Breast and Cervical Cancer Detection Program in Kansas. Welcome!
Early Detection Works Breast and Cervical Cancer Detection Program in Kansas Welcome! Our Mission: Protect and improve the health and environment for all Kansas residents. Early Detection Does Work 1.)
More informationAlabama Breast and Cervical Cancer Early Detection Program (ABCCEDP) County Health Department Protocol
Alabama Breast and Cervical Cancer Early Detection Program (ABCCEDP) County Health Department Protocol BREAST AND CERVICAL CANCER TABLE OF CONTENTS ABCCEDP Overview and Purpose... 1 Clinical Guidelines...
More informationCLINICAL DATA COLLECTION AND REPORTING MANUAL
WORKING DRAFT WORKING DRAFT WORKING DRAFT CONNECTICUT CANCER AND HEART DISEASE INTEGRATED HEALTH SCREENING PROGRAM (CCHDIHSP) CLINICAL DATA COLLECTION AND REPORTING MANUAL JULY 1, 2013 REQUIREMENTS FOR
More informationProgram Guidelines Clinical Guidelines Patient Enrollment Resource Documents Eligibility Guidelines... 2
BREAST AND CERVICAL CANCER TABLE OF CONTENTS Program Guidelines... 1 Clinical Guidelines... 1 Patient Enrollment... 1 Resource Documents... 1 Eligibility Guidelines... 2 Breast Screening Guidelines and
More informationI have no financial interests to disclose.
Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics I have no financial interests
More informationClinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary
Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary Glossary of Terms Colposcopy is the examination of the cervix, vagina and, in
More information2017 NBCCEDP Allowable Procedures and Relevant CPT Codes
2017 NBCCEDP Allowable Procedures and Relevant CPT Codes Listed below are allowable procedures and the corresponding suggested Current Procedural Terminology (CPT) codes for use in the National Breast
More informationFollow-up of Abnormal Breast Findings. E.J. Siegl RN, OCN, MA, CBCN BCCCP Nurse Consultant January 2012
Follow-up of Abnormal Breast Findings E.J. Siegl RN, OCN, MA, CBCN BCCCP Nurse Consultant January 2012 Abnormal Breast Findings include the following: CBE results of: Nipple discharge, no palpable mass
More informationQuick Reference Guide for Health Care Providers
Quick Reference Guide for Health Care Providers Breast and Cervical Cancer Screening and Treatment in Kentucky Kentucky Cancer Program Kentucky Department for Public Health For more information, contact:
More informationBC Cancer Cervix Screening 2015 Program Results. February 2018
BC Cancer Cervix Screening 2015 Program Results BC Cancer Cervix Screening 2015 Program Results 2 Table of Contents BC Cancer Cervix Screening 2015 Program Results... 1 Table of Contents... 2 Program Overview...
More informationFY 2015 BCCCP Procedure Code Reference Chart
Procedure Reference Chart 77057 G0202 77055 G0206 77056 G0204 Screening mammography, bilateral (two view film study of each breast) Screening mammography producing direct digital image, bilateral, all
More informationI have no financial interests in any product I will discuss today.
Cervical Cancer Screening Update and Implications for Annual Exams George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics
More informationFaculty Pap Smear Guidelines: Family Planning Update 2008 Part Two
Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Seshu P. Sarma, MD, FAAP Emory University Regional Training Center Atlanta, Georgia Produced by the Alabama Department of Public Health
More informationFY16 BCCS Reimbursement Rates and Billing Guidelines Appendix B 2
FY16 BCCS Reimbursement Rates and Billing Guidelines Appendix B 2 77053 Mammary ductogram or galactogram, single duct, Global Fee $59.05 May be billed with 77055, G0206, 77056, G0204, 76641, 76642 Billable
More informationCervical Cancer Screening Guidelines Update
Frontier AIDS Education and Training Center Cervical Cancer Screening Guidelines Update Hillary Liss, MD Harborview Medical Center, Madison and Adult Medicine Clinics Frontier AETC, Medical Program Director
More informationGuidelines for Breast, Cervical and Colorectal Cancer Screening
Guidelines for Breast, Cervical and Colorectal Cancer Screening Your recommendation counts. Talk to your patients about screening for cancer. CancerCare Manitoba provides organized, population-based screening
More informationServices can be paid by BCHC only for breast and/or cervical cancer screening and diagnosis. BCHC does not require preauthorization. OFFICE VISITS New Patient - Office Visit (0 minutes face to face) 9920
More information9/18/2008. Cervical Cancer Prevention for Adolescent Populations Garcia. Faculty disclosure. Objectives. HPV Positivity by Age (UK)
Faculty disclosure Cervical Cancer Prevention for Francisco, MD, MPH Associate Professor Obstetrics & Gynecology Mexican American Studies Public Health Francisco, MD, MPH has no financial affiliations
More informationManagament of Abnormal Cervical Cytology and Histology
Managament of Abnormal Cervical Cytology and Histology Ali Ayhan, M.D Başkent University Faculty of Medicine Department of Gynecology and Obstetrics Division of Gynecologic Oncology Abnormal Cytologic
More informationImproving Women s Health in South Carolina Best Chance Network and WISEWOMAN. Dr. Trenessa K. Jones Best Chance Network Program Director
Improving Women s Health in South Carolina Best Chance Network and WISEWOMAN Dr. Trenessa K. Jones Best Chance Network Program Director Presentation Objectives Overview the History and Need for the Best
More informationWOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES TREATMENT FORM FORM L16
WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES TREATMENT FORM FORM L16 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 05/01/95 ANY MISSING OR INCOMPLETE TEST RESULTS
More informationUnderstand Your Results
Understand Your Results The Pap test takes little time and may save your life. This simple screening test checks for cell changes in the cervix, the opening of the uterus. If your Pap results were abnormal,
More informationChapter 10: Pap Test Results
Chapter 10: Pap Test Results On completion of this section, the learner will be able to: 1. Identify how Pap test results are interpreted and the reasons for normal and abnormal results. 2. Describe the
More informationOver-diagnoses in Cytopathology: Is histology the gold standard?
Over-diagnoses in Cytopathology: Is histology the gold standard? Teresa M. Darragh, MD UCSF Departments of Pathology and Obstetrics, Gynecology & Reproductive Sciences Faculty Disclosures: Teresa M. Darragh,
More informationProtect yourself: Get screened for breast cancer
B Protect yourself: Get screened for breast cancer reast cancer is the most common form of cancer in women with the exception of skin cancer. Women should get annual exams from their healthcare provider
More informationManitoba Cervical Cancer Screening Program. Operations & Statistical Report and 2006
anitoba Cervical Cancer Screening Program Operations & Statistical Report 2005 and 2006 1 MCCSP 2005-2006 Report ANITOBA CERVICAL CANCER SCREENING PROGRAM 2005 and 2006 Operations & Statistical Report
More information!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$
!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$ Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology
More informationBreast Cancer Screening Database Reference Guide For Years
Breast Cancer Screening Database Reference Guide For Years 1996-2014 Compiled by: Edna Kalu, Zikuan Liu HOW TO OBTAIN MORE INFORMATION For more information about this guide or other services and data available
More informationYour Colposcopy Visit
Introduction Welcome to the colposcopy clinic. This booklet tells you about. The colposcopy examination.. Tests that are done in the colposcopy clinic.. What these tests look for Take a few minutes to
More informationScreening for Cervical Cancer: Demystifying the Guidelines DR. NEERJA SHARMA
Screening for Cervical Cancer: Demystifying the Guidelines DR. NEERJA SHARMA Cancer Care Ontario Cervical Cancer Screening Goals Increase patient participation in cervical screening Increase primary care
More informationCervical Cancer Screening. David Quinlan December 2013
Cervical Cancer Screening David Quinlan December 2013 Cervix Cervical Cancer Screening Modest variation provincially WHO and UK begin at 25 stop at 60 Finland begin at 30 stop at 60 Rationale for
More informationProgram Summary. The CT Early Detection and Prevention Program
Program Summary The CT Early Detection and Prevention Program 1 The CT Early Detection and Prevention Program is part of the Center for Disease Control and Prevention s (CDC) National Breast and Cervical
More informationLABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14
LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 08/5/94 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM.
More informationMaking Sense of Cervical Cancer Screening
Making Sense of Cervical Cancer Screening New Guidelines published November 2012 Tammie Koehler DO, FACOG The incidence of cervical cancer in the US has decreased more than 50% in the past 30 years because
More informationPopulation Prospective. Big Picture
Mai Elezaby, MD? Population Prospective Big Picture Breast Cancer Most common cancer in women 2 nd leading cause of death U.S. 2016 estimates 246,660 new cases 40,450 deaths from breast cancer https://seer.cancer.gov/statfacts/html/breast.html
More informationTreatment of Cervical Intraepithelial Neoplasia. Case. How would you manage this woman?
Treatment of Cervical Intraepithelial Neoplasia Karen Smith-McCune Professor, Department of Obstetrics, Gynecology and Reproductive Sciences I have no conflicts of interest Case How would you manage this
More informationNBCCEDP Program Manual: NBCCEDP Policies and Procedures Chapter
NBCCEDP Program Manual: NBCCEDP Policies and Procedures Chapter I. INTRODUCTION TO THE CHAPTER The NBCCEDP is grounded in Public Law, regulated by the Federal Government, and administered by the Centers
More informationThe society for lower genital tract disorders since 1964.
The society for lower genital tract disorders since 1964. Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology
More informationPROPOSED REGULATION OF THE STATE BOARD OF HEALTH. LCB File No. R July 30, 1997
PROPOSED REGULATION OF THE STATE BOARD OF HEALTH LCB File No. R038-97 July 30, 1997 EXPLANATION--Matter in italics is new; matter in brackets [ ] is material to be omitted. AUTHORITY: NRS 439.200. Section
More informationBREAST AND CERVICAL CANCER SCREENING PROGRAM POLICIES AND PROCEDURES MANUAL
BREAST AND CERVICAL CANCER SCREENING PROGRAM POLICIES AND PROCEDURES MANUAL Office of Maternal, Child and Family Health Bureau for Public Health West Virginia Department of Health and Human Resources 350
More informationUnderstanding Your Pap Test Results
Understanding Your Pap Test Results Most laboratories in the United States use a standard set of terms called the Bethesda System to report pap test results. Normal: Pap samples that have no cell abnormalities
More informationMultimodal Spectroscopic Imaging of the Cervix for Triaging Patients to Colposcopy
Multimodal Spectroscopic Imaging of the Cervix for Triaging Patients to Colposcopy L Twiggs, T De Santis, NM Chaktoura, D Ferris, L Flowers, M Lashgari, E Wilkinson, S Bambot, A Agrawal, and D Mongin EUROGIN
More informationAppropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines
Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates
More informationScreening Mammograms: Questions and Answers
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Screening Mammograms:
More informationColposcopy. Attila L Major, MD, PhD
Colposcopy Attila L Major, MD, PhD Histology Colposcopy Cytology It has been estimated that annual Pap smear testing reduces a woman s chance of dying of cervical cancer from 4 in 1000 to about 5 in 10,000
More informationCervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013
Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines General Principles: Since its introduction in 1943, Papanicolaou (Pap) smear is widely
More informationManagement of Abnormal Cervical Cytology and Histology
Management of Abnormal Cervical Cytology and Histology Assoc. Prof. Gökhan Tulunay Etlik Zübeyde Hanım Women s Diseases Teaching & Research Hospital Gynecologic Oncology Clinic Universally accepted guideline
More informationClinical outcomes after conservative management of CIN1/2, CIN2, and CIN2/3 in women ages years
Clinical outcomes after conservative management of CIN1/2, CIN2, and CIN2/3 in women ages 21-39 years Michelle I. Silver, PhD, ScM Cancer Prevention Fellow National Cancer Institute Division of Cancer
More informationI have no financial interests in any product I will discuss today.
Cervical Cancer Prevention: 2012 and Beyond George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics University of California,
More informationProposed new national cervical screening program. Dr Elizabeth Jackson Obstetrician Gynaecologist Cairns
Proposed new national cervical screening program Dr Elizabeth Jackson Obstetrician Gynaecologist Cairns www.drelizabethjackson.com Cervical cancer in Australia 12th most common cancer affecting Australian
More informationWhat Causes Cervical Cancer? Symptoms of Cervical Cancer
Cervical Health Awareness Month is a chance to raise awareness about how women can protect themselves from HPV (human papillomavirus) and cervical cancer. HPV is a very common infection that spreads through
More informationUpdated ASCCP Consensus Guidelines For Managing Diagnosed Cervical Cancer Precursors Michael A. Gold, M.D.
Updated ASCCP Consensus Guidelines For Managing Diagnosed Cervical Cancer Precursors Michael A. Gold, M.D. 27 May, 2014 London, England Faculty Disclosure X No, nothing to disclose Yes, please specify
More informationAccess to Medicaid for Breast & Cervical Cancer Treatment:
Access to Medicaid for Breast & Cervical Cancer Treatment: What s New for Women s Health Connection and Your Patients? Presented by: Nevada Cancer Coalition This webinar supported by Nevada State Health
More informationCervical Cancer Screening Update. Melissa Hartman, DO Women s Health
Cervical Cancer Screening Update Melissa Hartman, DO Women s Health Previous Cervical Cancer Screening Organization Recommendation ACS (2011) ACP (2008) NCI (2003) Age 21 or 3 years after first intercourse
More informationEradicating Mortality from Cervical Cancer
Eradicating Mortality from Cervical Cancer Michelle Berlin, MD, MPH Vice Chair, Obstetrics & Gynecology Associate Director, Center for Women s Health June 2, 2009 Overview Prevention Human Papilloma Virus
More informationPap Smears Pelvic Examinations Well Woman Examinations. When should you have them performed???
Pap Smears Pelvic Examinations Well Woman Examinations. When should you have them performed??? Arlene Evans-DeBeverly, PA-C Copyright 2012 There are always ongoing changes in gynecology, including the
More informationBreast and Ovarian Cancer
Patient Education Breast and Ovarian Cancer Screening and detection The goal of screening for cancer is to find it as early as possible, when it is easiest to cure. This handout describes the symptoms
More informationJean Anderson, MD Catherine Sewell, MD, MPH
Jean Anderson, MD Catherine Sewell, MD, MPH To review diagnosis and management of HPV disease in the setting of HIV infection and address controversies HIV-infected women have: higher prevalence and incidence
More informationHealthy Texas Women. Viveca Martinez, Deputy Associate Commissioner Health and Human Services
Healthy Texas Women Viveca Martinez, Deputy Associate Commissioner Health and Human Services Agenda Healthy Texas Women(HTW) HTW Enrollment Methods HTW Program Benefits Family Planning Program (FPP) Breast
More informationDysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.
CLINICAL PRACTICE GUIDELINE Guideline Number: DHMP_DHMC_PG1015 Guideline Subject: Routine Cervical Cancer Screening Effective Date: 9/2018 Revision Date: 9/2019 Pages: 2 of 2 Quality Management Committee
More informationBroward Health s Breast Cancer Navigation Program Meeting the needs of underserved patients
Broward Health s Breast Cancer Navigation Program Meeting the needs of underserved patients by Pia Delvaille, ARNP, MSN Broward Health, a nonprofit community health system, is one of the ten largest public
More informationConflict of Interest Disclosure. Anita L. Nelson, MD. Principles Underlying Screening Recommendations. Learning Objectives
Advanced Colposcopy Conflict of Interest Disclosure Anita L. Nelson, MD Anita L. Nelson, MD Professor OB-GYN David Geffen School of Medicine at UCLA CFHC s 2014 Women s Health Update Berkeley, CA May 20,
More informationBreast Evaluation & Management Guidelines
Breast Evaluation & Management Guidelines Pamela L. Kurtzhals, M.D. F.A.C.S. Head, Dept. of General Surgery Scripps Clinic, La Jolla Objective Review screening & diagnostic guidelines Focused patient complaints
More informationUpdate on Cervical Cancer Screening. Rahmouna Farez M.D. Assistant Professor, Medical College of Wisconsin 5/2/2014
Update on Cervical Cancer Screening Rahmouna Farez M.D. Assistant Professor, Medical College of Wisconsin 5/2/2014 Objectives Review the natural history of HPV as it relates to cervical cancer screening
More informationUpdate on Cervical Cancer Screening
Update on Cervical Cancer Screening Rahmouna Farez M.D. Assistant Professor, Medical College of Wisconsin 5/2/2014 Objectives Review the natural history of HPV as it relates to cervical cancer screening
More informationNovember 23, Dear Maryland Breast and Cervical Cancer Program Provider:
STATE OF MARYLAND DHMH Maryland Department of Health and Mental Hygiene 201 W. Preston Street Baltimore, Maryland 21201 Martin O Malley, Governor Anthony G. Brown, Lt. Governor John M. Colmers, Secretary
More informationCervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH
Cervical Testing and Results Management An Evidenced-Based Approach April 22nd, 2010 Debora Bear, MSN, MPH Assistant Medical Director for Planned Parenthood of New Mexico, Inc. Burden of cervical cancer
More informationPreventive Care Guideline for Asymptomatic Elderly Patients Age 65 and Over
Preventive Care Guideline for Asymptomatic Elderly Patients Age 65 and Over 1. BMI - Documented in patients medical record on an annual basis up to age 74. Screen for obesity and offer counseling to encourage
More informationCVIM s Cancer Screening Practices
12-13-17 Professional Practice Minutes CVIM s Cancer Screening Practices At CVIM, preventative health care is very important! In these minutes you will find a review of our recommendations for cancer screening
More informationCervical Dysplasia and HPV
Cervical Dysplasia and HPV J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse HPV Double stranded DNA virus The HPV infect epithelial cells of the skin and mucous membranes Highest risk
More informationAnthem Pay-for- Performance (HEDIS )*
Serving Hoosier Healthwise, Healthy Indiana Plan Anthem Pay-for- Performance (HEDIS )* [Candace Adye, RN Amanda Gonzalez, RN] *HEDIS is a registered trademark of the National Committee for Quality Assurance
More informationDepartment of Health Standard for the Cervical Cancer Screening Program. Approval Date: 08 May 2018 Effective Date: 13 May 2018
Document Title: Department of Health Standard for the Cervical Cancer Screening Program Document Ref. Number: DOH/CCSC/SD/1.0 Version: 1.0 Approval Date: 08 May 2018 Effective Date: 13 May 2018 Last Reviewed:
More informationHPV and Cervical Cancer, Screening and Prevention. John Ragsdale, MD July 12, 2018 CME Lecture Series
HPV and Cervical Cancer, Screening and Prevention John Ragsdale, MD July 12, 2018 CME Lecture Series We have come a long Way Prevalence HPV in Young Adults in U.S HPV genotypes 55-60% of All cancers 20%
More informationOSCAR EMR Cancer Screening Guidelines
OSCAR EMR Cancer Screening Guidelines Version 2.3 November 2018 Cancer Care Ontario Primary Care Lead (HNHB LHIN) Table of Contents OSCAR EMR Cancer Screening Guidelines 1. INTRODUCTION GETTING READY...
More informationPut i2itracks on the Fast Track. Nancy Thompson
Put i2itracks on the Fast Track Nancy Thompson Welcome Currently Fast Track Solutions Built-in Software Solutions Professional Services Step-by-Step Instructions Best Practices Community Knowledge on Demand
More information2018 Preventive Schedule
2018 Preventive Schedule Medicare-Covered Services PLAN YOUR CARE: KNOW WHAT YOU NEED AND WHEN TO GET IT Preventive or routine care helps us stay well or finds problems early, when they are easier to treat.
More informationCancer Prevention and Control, Client-Oriented Screening Interventions: Reducing Client Out-of-Pocket Costs Colorectal Cancer (2008 Archived Review)
Cancer Prevention and Control, Client-Oriented Screening Interventions: Reducing Client Out-of-Pocket Costs Colorectal Cancer (2008 Archived Review) Table of Contents Review Summary... 2 Intervention Definition...
More informationUpdates In Cancer Screening: Navigating a Changing Landscape
Updates In Cancer Screening: Navigating a Changing Landscape Niharika Dixit, MD I have no conflict of interest. 1 Why Should You Care Trends in Cancer Incidence by Site United States. Siegal Et al: CA
More informationI have no financial interests in any product I will discuss today.
Cervical Cancer Screening Update and Implications for Annual Exams George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics
More informationLauren O Sullivan, D.O. February 19, 2015
Lauren O Sullivan, D.O. February 19, 2015 1. Review basics of Pap smear, cervical dysplasia/cancer and HPV infection. 2. Review 2012 updated screening guidelines. 3. Discuss how and where to find updated
More informationObjectives. I have no financial interests in any product I will discuss today. Cervical Cancer Screening Guidelines: Updates and Controversies
Cervical Cancer Screening Guidelines: Updates and Controversies I have no financial interests in any product I will discuss today. Jody Steinauer, MD, MAS University of California, San Francisco Objectives
More informationSchedule of Fees for Covered Services
Schedule of s for Covered Services Based on Medicare Part B Rates and effective January 1, 2019 Ladies First is a federally funded program that can pay for breast and cervical cancer screenings and diagnostics.
More informationBreastScreen Victoria Annual Statistical Report
BreastScreen Victoria Annual Statistical Report 005 Produced by: BreastScreen Victoria Coordination Unit Level, Pelham Street, Carlton South Victoria 05 PH 0 9660 6888 FX 0 966 88 EM info@breastscreen.org.au
More informationASCCP 2013 Guidelines for Managing Abnormal Cervical Cancer Screening Tests
ASCCP 2013 Guidelines for Managing Abnormal Cervical Cancer Screening Tests www.treatmentok.com Barbara S. Apgar, MD, MS Professor of Family Medicine University of Michigan Ann Arbor, Michigan Disclosures
More information